Sign In for increased benefits

Turn your one-off questions into a powerhouse research hub.

  • 🚨Real-time alerts on your custom watchlists
  • 🔍Unlock Deep Research Mode
  • 📊Exportable PDF/Word reports
  • 📚Revisit every question in your account history
  • ⭐Get personalised research and news based on your past questions
  • 🤝Team collaborate & annotate insights
  • 🌐Sync across devices—never lose your place
  • 👑Early-access to the next big AI features
  • 📚Continue enjoying 40 questions daily on your free account
About UsFAQsContact UsPrivacy PolicyCookies PolicyTerms and ConditionAcceptable Use PolicyData Processing Addendum
📢 New Earnings In! 🔍
Latest EarningsEarnings ChatEarnings FeedCompanies

Relmada Therapeutics, Inc.

RLMD

Healthcare
Biotechnology
US

Company Overview

Detailed information about Relmada Therapeutics, Inc.

Basic Information
Ticker: RLMD
Country: US
Headquarter: Coral Gables, FL
Employees: 17
Financial Information
Market Cap: $22.2 Million
Currency: USD
Sector: Healthcare
Industry: Biotechnology

Stock Data provided by Financial Modeling Prep

Company Description

Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that is in Phase 3 clinical trials for the adjunctive or monotherapy treatment of major depressive disorder in adults. The company was founded in 2004 and is headquartered in Coral Gables, Florida.

Last Updated: Jul 2025

Here's what you can ask